中国热点论文榜
中国科学院文献情报中心科学计量中心

表5 中国医学领域热点论文(2014–2018年)
序号 论文题目 作者机构 被引频次
1 He Jie*等. Cancer statistics in China, 2015. CA-A Cancer Journal for Clinicians, 2016, 66(2), 115-132. 国家癌症中心† 5530
2 Liu Jianhua*, Shen Jianzhong*等. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infectious Diseases, 2016, 16(2), 161-168. 华南农业大学†, 中国农业大学† 1468
3 Wu Yilong*等. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial. Lancet Oncology, 2014, 15(2), 213-222. 广东省医学科学院&广东省人民医院广东省肺癌研究所† 882
4 Mok Tony S*等. Osimertinib or platinum-pemetrexed in EGFR T790m-positive lung cancer. New England Journal of Medicine, 2017, 376(7), 629-640. 香港中文大学† 711
5 Shao Feng*等. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature, 2015, 526(7575), 660-665. 北京生命科学研究所† 640
6 Tong Tiejun*等. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology, 2014, 14. 香港浸会大学† 616
7 Shao Feng*等. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature, 2014, 514(7521), 187-192. 北京生命科学研究所† 522
8 Wang Xia等. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ-British Medical Journal, 2014, 349. 山东大学,华中科技大学 518
9 Fan Lei等. Breast cancer in China. Lancet Oncology, 2014, 15(7), E279-E289. 复旦大学 486
10 Li Lanjuan*, Zheng Shusen*等. Alterations of the human gut microbiome in liver cirrhosis. Nature, 2014, 513(7516), 59-64. 浙江大学† 475